Method for preparing hydrangea-shaped layered double hydroxide
The co-precipitation method for producing hydrangea-type LDH with a large specific surface area addresses the stability issues of cosmetic active ingredients, enhancing their delivery and efficacy in cosmetic compositions.
Patent Information
- Application Number
- PCT/KR2024/007081
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-26
- Filing Date
- 2024-05-24
- Publication Date
- 2024-12-05
AI Technical Summary
Existing methods for producing layered double hydroxides (LDH) do not effectively provide a large specific surface area, which is necessary for stable delivery of cosmetic active ingredients, as they are prone to degradation from light, heat, and oxygen.
A method involving the co-precipitation of a mixed solution containing divalent and trivalent metal cations with a NaOH solution at pH 9 to 11, followed by filtration and drying, to produce hydrangea-type LDH with a large specific surface area, enhancing its stability and delivery capabilities.
The method efficiently produces LDH with a large specific surface area, enabling stable delivery of cosmetic active ingredients, as demonstrated by increased skin moisture and keratin improvement in experimental examples.
Smart Images

Figure KR2024007081_05122024_PF_FP_ABST
Abstract
Description
Method for producing a hydrangea-type layered double hydroxide
[0001] The present invention relates to a method for producing a hydrangea-type layered double hydroxide, and more specifically, to a method for producing a hydrangea-type layered double hydroxide having a large specific surface area by a co-precipitation method in which a mixed solution of a solution containing a divalent metal cation and a solution containing a trivalent metal cation and a NaOH solution are added to a solution containing an anion while maintaining the pH at 9 to 11.
[0002] Various encapsulation technologies are being studied to provide greater stability to unstable cosmetic raw materials. In particular, it is well known that light, heat, and oxygen in the air can severely reduce the biological activity of functional raw materials.
[0003] Layered double hydroxide (LDH) is one of the delivery systems for these cosmetic active ingredients. LDH is an inorganic compound with a layered structure, and its shape resembles the leaflets of a stratum corneum. The composition of LDH is generally [M 2+ 1-x M 3+ x (OH)2] x+ (A n- ) x / n ·It is expressed by the structural formula of mH2O. In the above structural formula, M 2+ Wow M 3+ is a metal cation that occupies the octahedral site of brucite, and A n- represents an anion located between layers. In general, in a fixed composition state, 0.2 ≤ x ≤ 0.33, n is 1 or 2, and m is 0.5 to 4.
[0004] LDH is an inorganic material with structural properties that enable it to absorb a variety of anions, ranging from small gas molecules like carbon dioxide to biopolymers like DNA. Furthermore, molecules trapped within the layer can be maintained energetically stable through electrostatic interactions with the inorganic layer. Anions can be absorbed or released via ion exchange. Because the inorganic layer consists of a variety of compositions, ranging from alkaline metals to transition metals, it can be used as a precursor material for catalysts, magnetic materials, and electronic materials. Recently, mechanisms have been discovered that utilize specific molecular linkages to self-assemble LDH nanomaterials or selectively induce surface reactions within the inorganic layer to control the release of anions within the layer under specific environments, leading to interest in gas sensors and drug delivery materials. In particular, if the electrostatic attraction existing between layers is chemically minimized, it can be separated into nanolayers with a thickness of 1 nm, which has become a detonator that explosively increases the applicability of LDH materials, and it is being applied in fields such as nanoelectronics, magento-optics, and nanosensors. In addition, LDH nanolayers with excellent adsorption performance for functional organic molecules are attracting attention as new bioencapsulation materials based on the development of technologies such as improving the adsorption performance of effective cosmetics ingredients and controlling release according to chemical environment control. As an example of a method for manufacturing such LDH, Republic of Korea Patent Publication No. 10-2019-0019150 discloses a manufacturing method that imparts high surface area and pore volume properties to LDH by including a specific solvent treatment step during manufacturing.
[0005] [Prior Art Literature]
[0006] [Patent Document]
[0007] Republic of Korea Patent Publication No. 10-2019-0019150
[0008] Accordingly, the present invention has as its technical task a method for producing a layered double hydroxide having the above-described advantages in a form with a large specific surface area, thereby enabling various functional cosmetic raw materials to be efficiently delivered into the skin in a more stable state.
[0009] In addition, another technical object of the present invention is to provide a cosmetic composition comprising a layered double hydroxide prepared according to the above method and an active ingredient.
[0010] In order to solve the above problem, the present invention provides a method for producing a layered double hydroxide having a large specific surface area by a co-precipitation method in which a mixed solution of a solution containing a divalent metal cation and a solution containing a trivalent metal cation and a NaOH solution are added to a solution containing an anion while maintaining the pH at 9 to 11.
[0011] In addition, the present invention provides a cosmetic composition comprising a layered double hydroxide prepared by the above method and an active ingredient.
[0012]
[0013] The present invention is described in detail below.
[0014]
[0015] According to one aspect of the present invention,
[0016] i) A mixed solution of a solution containing a divalent metal cation and a solution containing a trivalent metal cation and a NaOH solution are added to a solution containing an anion while maintaining the pH at 9 to 11;
[0017] ii) Stirring the mixed solution obtained in step (i);
[0018] iii) The result obtained in step (ii) is filtered using a Buchner funnel and then washed with distilled water until the pH becomes 6 to 8;
[0019] iv) Add a solvent to the resultant product collected at the top of the Buchner funnel obtained in step (iii) above and then stir;
[0020] v) A method for producing a hydrangea-type layered double hydroxide is provided, which comprises filtering the result obtained in the above step (iv) using a Buchner funnel and then drying it.
[0021]
[0022] The layered double hydroxide manufactured according to the manufacturing method of the present invention can provide a large specific surface area in the form of a hydrangea flower (see FIGS. 4 and 5), and is therefore referred to herein as a “hydrangea-shaped layered double hydroxide.”
[0023] In one specific embodiment according to the present invention, the divalent metal cation of step (i) is Ca 2+ , Mg 2+ , Zn 2+ , Ni 2+ , Mn 2+ , Co 2+ or Fe 2+ It may include, but is not limited to.
[0024] In one specific example according to the present invention, the trivalent metal cation of step (i) is Al 3+ , Cr 3+ , Mn 3+ , Fe 3+ , Ga 3+ , Co 3+ or Ni 3+ It may include, but is not limited to.
[0025] In one specific example according to the present invention, the anion of step (i) is OH - , F - , Cl- , Br - , I - , NO3 - , CO3 2- or SO4 2- It may include, but is not limited to.
[0026] According to one specific example of the present invention, in step (i), NaOH can be used at a concentration of 2 to 5 M, 3 to 5 M, 3.5 to 4.5 M, or 4 M.
[0027] According to one specific example of the present invention, the pH of the solution containing anions in step (i) can be maintained at 9.2 to 10.8, or 10 ± 0.5.
[0028] According to one specific example of the present invention, in step (i), a mixed solution of a solution containing a divalent metal cation and a solution containing a trivalent metal cation and a NaOH solution may be added to a solution containing an anion at a rate of 1 to 4 mL / min, 1.2 to 3 mL / min, or 1.5 to 2.5 mL / min.
[0029] According to one specific example of the present invention, in step (ii), the mixed solution may be stirred for 30 minutes to 2 hours, 40 minutes to 1.5 hours, or 1 hour.
[0030] According to one specific example of the present invention, in step (iii), the solution may be filtered using a Buchner funnel and then washed with distilled water until the pH reaches 6 to 8, or 7.
[0031] According to one specific example of the present invention, in step (iii), washing may be performed with distilled water until the pH reaches 6 to 8, and then further washing may be performed with ethanol.
[0032] In one specific example according to the present invention, the solvent in step (iv) may be ethanol.
[0033] According to one specific example of the present invention, the stirring in step (iv) may be performed for 12 to 36 hours, 16 to 32 hours, or 20 to 28 hours.
[0034] According to one specific example of the present invention, drying in step (v) can be performed at room temperature using a vacuum chamber.
[0035] In one specific example according to the present invention, the hydrous layered double hydroxide prepared according to the above method has a molecular weight of 200 m 2 / g or more, 210 m 2 / g or more, 220 m 2 / g or more, 230 m 2 / g or more, 240 m 2 / g or more, 250 m 2 / g or more, 260 m 2 / g or more, 270 m 2 / g or more, or 280 m 2 / g or more. In one specific embodiment according to the present invention, the hydrous layered double hydroxide prepared according to the above method has a BET surface area of, for example, 250 to 300 m 2 / g can have a BET surface area.
[0036]
[0037] According to another aspect of the present invention, a cosmetic composition comprising a hydrous layered double hydroxide produced by the production method according to the present invention and an active ingredient is provided.
[0038]
[0039] In one specific example according to the present invention, the active ingredient may be one or more selected from the group consisting of, for example, a moisturizer, a whitening agent, an anti-wrinkle agent, a sunscreen, a hair growth agent, a vitamin or a derivative thereof, an amino acid or peptide, an anti-inflammatory agent, an acne treatment agent, a bactericidal agent, a female hormone agent, an exfoliating agent, and a natural product, but is not limited thereto.
[0040] Examples of moisturizers include, but are not limited to, creatine, polyglutamic acid, sodium lactate, hydrolyzed proline, sodium 2-pyrrolidone-5-carboxylate, hyaluronic acid, sodium hyaluronate, ceramides, phytosteryls, cholesterol, sitosterol, pullulan, proteoglycans, etc. Examples of whitening agents include, but are not limited to, arbutin and arbutin derivatives, kojic acid, bisabolol, niacinamide, vitamin C and vitamin C derivatives, placenta, allantoin, madecassoside, etc. Examples of wrinkle-improving agents include, but are not limited to, retinol, retinol derivatives, retinal, adenosine, licorice extract, red ginseng extract, ginseng extract, etc. Examples of sunscreens include, but are not limited to, benzophenone derivatives, para-aminobenzoic acid derivatives, methoxycinnamic acid derivatives, salicylic acid derivatives, and avobenzone. There are no particular limitations on hair growth agents, but blood circulation promoters and / or local irritants are preferred. Examples of blood circulation promoters include, but are not limited to, laurel extract, cephalantin, vitamin E and its derivatives, and gamma oryzanol. Examples of local irritants include, but are not limited to, red pepper tincture, ginger tincture, cantharis tincture, and nicotinic acid benzyl ester. Examples of vitamins or their derivatives include, but are not limited to, vitamin A (retinol) and its derivatives, vitamins B1, B2, B6, vitamin E and its derivatives, vitamin D, vitamin H, vitamin K, pantothenic acid and its derivatives, biotin, panthenol, and coenzyme Q. 10, idebenone, etc., but are not limited thereto. Amino acids or peptides include, for example, cysteine, methionine, serine, lysine, tryptophan, amino acid extracts, epidermal growth factor (EGF), insulin-like growth factor (IGF), fibroblast growth factor (FGF), copper peptide, copper tripeptide-1, tripeptide-29, tripeptide-1, acetyl hexapeptide-8, nicotinoyl tripeptide-35, hexapeptide-12, hexapeptide-9. Examples include, but are not limited to, palmitoyl pentapeptide-4, palmitoyl tetrapeptide-7, palmitoyl tripeptide-29, palmitoyl tripeptide-1, nonapeptide-7, tripeptide-10 citrulline, sh-polypeptide-15, palmitoyl tripeptide-5, diaminopropioyl tripeptide-33, r-spider polypeptide-1, etc. Anti-inflammatory agents include, but are not limited to, beta-glycyrrhizic acid, glycyrrhizic acid derivatives, aminocaproic acid, hydrocortisone, beta-glucan, licorice, etc. Acne treatments include, but are not limited to, estradiol, estrogen, ethinyl estradiol, triclosan, azelaic acid, etc. Examples of antiseptics include, but are not limited to, benzalkonium chloride, benzethonium chloride, and halocarban. There are no specific restrictions on female hormones, but estrogen is suitable, and estradiol, ethinyl estradiol, and isoflavones, which are plant estrogens, are preferable. Examples of exfoliating and dissolving agents include, but are not limited to, sulfur, salicylic acid, alpha hydroxy acid (AHA), beta hydroxy acid (BHA), and resorcin.Extracts of natural products or ingredients obtained from them, such as extracts of Korean ginseng, common angelica, white chrysanthemum, rhubarb, licorice, aloe, chamomile, rosehip, horse chestnut, ginseng, loofah, cucumber, laver, seaweed, hemp, snail, young lady, and centella asiatica, as well as hinokitiol and beta-carotene, are not limited thereto. In addition, there are yeast extracts, collagen, elastin, DHA, EPA, and fragrance ingredients.
[0041] The cosmetic composition of the present invention may additionally include ingredients such as a stabilizer, an antioxidant, and a lubricant, as needed.
[0042] The hydrangea-shaped layered double hydroxide prepared according to the present invention can deliver cosmetic active ingredients into the skin very efficiently in a stable form by providing a large specific surface area.
[0043] Figure 1 is a schematic diagram schematically showing the manufacturing method of Example 1.
[0044] Figure 2 is a photograph showing a volume comparison experiment of the layered double hydroxide (HLDH) of the present invention and a general layered double hydroxide (PLDH).
[0045] Figure 3 shows the FT-IR analysis results of the layered double hydroxide (HLDH) of the present invention and the general layered double hydroxide (PLDH).
[0046] Figure 4 is a photograph of the layered double hydroxide (HLDH) of the present invention and a typical layered double hydroxide (PLDH) taken using a scanning electron microscope.
[0047] Figure 5 is a photograph taken using a scanning electron microscope of HLDH containing avobenzone of Example 2 and PLDH containing avobenzone of Comparative Example 1.
[0048] Figure 6 shows the FT-IR analysis results of HLDH containing avobenzone of Example 2 and PLDH containing avobenzone of Comparative Example 1.
[0049] Figure 7 shows the HPLC analysis results of HLDH containing avobenzone of Example 2 and PLDH containing avobenzone of Comparative Example 1.
[0050] Figure 8 shows the results of measuring particle distribution and zeta potential in Experimental Example 3.
[0051] Figure 9 is a graph showing the results of measuring the degree of improvement in skin moisture content in Experimental Example 5.
[0052] Figure 10 is a graph showing the skin moisture content improvement rate measured in Experimental Example 5.
[0053] Figure 11 is a graph showing the results of measuring the degree of improvement in skin keratin index in Experimental Example 6.
[0054] Figure 12 is a graph showing the skin keratin index improvement rate measured in Experimental Example 6.
[0055] Hereinafter, the present invention will be described in more detail through examples. However, the following examples are provided merely to aid understanding of the present invention and are not intended to limit the scope of the present invention.
[0056]
[0057] Example 1: Preparation of a hydrangea-shaped layered double hydroxide
[0058] A hydrous layered double hydroxide containing carbonate ions was synthesized by coprecipitation as follows.
[0059] A mixed solution (A) containing 1.875 M Mg(NO3)2·6H2O (Deoksan Science, Korea) and 0.625 M Al(NO3)3·9H2O (Deoksan Science, Korea) in distilled water and a solution (B) containing 4 M NaOH (Deoksan Science, Korea) were slowly added to a 0.5 M Na2CO3 (Deoksan Science, Korea) solution (C) using a pump. The pH of the mixed solution (C) was maintained at 10.0 ± 0.5 during the addition. After stirring the mixed solution for about 1 hour, it was filtered using a Buchner filter, washed with distilled water until the pH reached 7, and then washed using ethanol. The clay collected on the upper part of the Buchner was placed back into ethanol and stirred for a day, filtered using a Buchner, and vacuum-dried at room temperature using a vacuum chamber to obtain hydrangea-shaped layered double hydroxide (hereinafter referred to as “HLDH”). The structural formula of the synthesized HLDH is as follows: [Mg3Al(OH)8]CO3·xH2O]
[0060] For comparison with the above HLDH, a common layered double hydroxide, Mg4Al2(OH) 12 CO33H2O (plate-shaped layered double hydroxide, hereinafter referred to as “PLDH”) was purchased from Danseok Industry (Korea).
[0061]
[0062] Example 2: Preparation of HLDH containing avobenzone
[0063] 6 g of PARSOL ®1789 (avobenzone) was dispersed in a 1:1 ratio of water and ethanol, and 50 mL of distilled water containing 1.5 g of sodium hydroxide was added thereto, followed by stirring at room temperature for 30 minutes. 10 g of HLDH was added to the mixture, stirred at 80°C for 5 hours, and then washed and filtered using hot distilled water and ethanol using a Buchner filter. The clay collected on top of the Buchner filter was vacuum-dried at room temperature using a vacuum chamber.
[0064]
[0065] Comparative Example 1: Preparation of PLDH containing avobenzone
[0066] PLDH containing avobenzone was prepared in the same manner as in Example 2, except that PLDH was used instead of HLDH.
[0067]
[0068] Example 3: Preparation of HLDH containing collagen
[0069] 10 g of collagen was dissolved in water and stirred for 30 minutes. 10 g of HLDH was added to the mixture, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0070]
[0071] Example 4: Preparation of HLDH containing hyaluronic acid
[0072] 0.5 g of hyaluronic acid was dissolved in water and stirred for 30 minutes. 10 g of HLDH was added to the mixture, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0073]
[0074] Example 5: Preparation of HLDH containing ceramide
[0075] 1.5 g of ceramide was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0076]
[0077] Example 6: Preparation of HLDH containing retinol
[0078] 4.5 g of retinol was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0079]
[0080] Example 7: Preparation of HLDH containing retinol
[0081] 5 g of retinol was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0082]
[0083] Example 8: Preparation of HLDH containing arbutin
[0084] 5 g of arbutin was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0085]
[0086] Example 9: Preparation of HLDH containing tocopherol
[0087] 5 g of tocopherol was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0088]
[0089] Example 10: Preparation of HLDH containing EGF
[0090] 5 g of epidermal growth factor (EGF) was dissolved in water and stirred for 30 minutes. 10 g of HLDH was added to the mixture, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0091]
[0092] Example 11: Preparation of HLDH containing copper peptide
[0093] 5 g of copper peptide was dissolved in water and stirred for 30 minutes. 10 g of HLDH was added to the mixture, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0094]
[0095] Example 12: Preparation of HLDH containing beta-glucan
[0096] 5 g of beta-glucan was dispersed in water and stirred for 30 minutes. 10 g of HLDH was added to the mixture, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0097]
[0098] Example 13: Preparation of HLDH containing isoflavones
[0099] 5 g of isoflavone was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0100]
[0101] Example 14: Preparation of HLDH containing salicylic acid
[0102] 5 g of salicylic acid was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0103]
[0104] Example 15: Preparation of HLDH containing Centella asiatica extract
[0105] 5 g of the extract of the purslane was dispersed in water and stirred for 30 minutes. 10 g of HLDH was added to the mixture, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0106]
[0107] Example 16: Preparation of HLDH containing madecassoside
[0108] 5 g of madecassoside was dispersed in a 1:1 ratio of water and ethanol, and stirred for 30 minutes. 10 g of HLDH was added to the mixed solution, stirred at room temperature for 24 hours, and then washed and filtered using distilled water and ethanol using a centrifuge. The clay collected at the bottom was vacuum-dried at room temperature using a vacuum chamber.
[0109]
[0110] Example 17 and Comparative Example 2: Preparation of a cream containing avobenzone
[0111] The ingredients of phases A, B-1, B-2, and C in Table 1 below were mixed respectively. Phases A and B-2 were mixed at 75°C or higher. After the ingredients were completely dissolved, they were mixed and mixed using a homogenizer for a certain period of time and cooled to produce a cream.
[0112] [Table 1]
[0113]
[0114]
[0115] Example 18 and Comparative Example 3: Preparation of a cream containing hyaluronic acid
[0116] The ingredients of phases A, B-1, B-2, and C in Table 2 below were mixed respectively. Phases A and B-2 were mixed at 75°C or higher. After the ingredients were completely dissolved, they were mixed and mixed using a homogenizer for a certain period of time and cooled to produce a cream.
[0117] [Table 2]
[0118]
[0119]
[0120] Example 19 and Comparative Example 4: Preparation of a cream containing retinol
[0121] The ingredients of phases A, B-1, B-2, and C in Table 3 below were mixed respectively. Phases A and B-2 were mixed at 75°C or higher. After the ingredients were completely dissolved, they were mixed and mixed using a homogenizer for a certain period of time and cooled to produce a cream.
[0122] [Table 3]
[0123]
[0124]
[0125] Experimental Example 1: LDH Analysis
[0126] When PLDH and HLDH of the present invention were measured by BET, 150 m of PLDH 2 / g while HLDH is 285.58 m 2 / g HLDH with a hydrangea shape was confirmed to have a large specific surface area. In addition, a volume comparison experiment was conducted to confirm that HLDH was 4 times higher when the same amount of 2 g was placed in the same vial (Fig. 2).
[0127] The structure of the synthesized HLDH was confirmed by identifying chemical functional groups through FT-IR (Fourier-transform infrared spectroscopy) analysis (Fig. 3). 3,250–3,500 cm -1The broad absorption band observed in the region is due to the hydroxyl group (OH) in PLDH, at 1,655 cm -1 The strong absorption band appearing in the region is an anion carbonate (CO3 2- ) is shown by 900 cm -1 The absorption bands appearing in this region are due to the combination of aluminum and oxygen and magnesium and oxygen.
[0128] Additionally, the shape and size of PLDH and HLDH of the present invention were examined using a scanning electron microscope (SEM) (Fig. 4). PLDH exhibited a plate-like structure, while HLDH was found to have a hydrangea-like shape. This supports the BET analysis results showing that HLDH had a larger specific surface area.
[0129]
[0130] Experimental Example 2: LDH Analysis Containing Avobenzone
[0131] FT-IR analysis was performed to analyze the structure of HLDH containing avobenzone of Example 2 and PLDH containing avobenzone of Comparative Example 1. 3,250-3,500 cm -1 , 1,655 cm -1 , 900 cm -1 Each absorption band was identified in the region, and additionally PARSOL ® 2,970 cm as the absorption band of 1789 (avobenzone) -1 Absorption band of carbon and hydrogen bond (CH), 1,600 cm -1 Double bond of carbon and oxygen (C=O), 1,050–1,250 cm -1 A peak of single bonds of carbon and oxygen (CO) appeared in .
[0132] In addition, the shape and size of HLDH of Example 2 and PLDH of Comparative Example 1 could be confirmed from the SEM analysis results (Fig. 5). In particular, in the case of HLDH of Example 2, PARSOL was evenly distributed between the hydrangea-shaped particles with a large specific surface area. ® It was found that 1789 was captured. In addition, the active ingredient PARSOL ® To confirm whether 1789 was trapped in the layered double hydroxide, analysis was performed using a UV-vis spectrophotometer using ethanol solvent (Fig. 6). The existing PARSOL ® In the case of 1789, the max peak value is shown at 358 nm, and it was confirmed that both HLDH of Example 2 and PLDH of Comparative Example 1 have the max peak value at 358 nm, and HLDH of Example 2 appears to have a higher onset value, which is confirmed by PARSOL ® It was found that the content of 1789 was higher.
[0133] PARSOL in HLDH of Example 2 and PLDH of Comparative Example 1 ® High-performance liquid chromatography (HPLC) analysis was performed to quantitatively analyze the 1789 content (Fig. 7). While the PLDH of Comparative Example 1 showed 12.56%, Example 2, which used hydrangea-shaped HLDH with a large specific surface area, showed a content of approximately twice as high at 26.71%.
[0134]
[0135] Experimental Example 3: Measurement of particle distribution and zeta potential
[0136] The particle distribution and zeta potential of PLDH and HLDH containing hyaluronic acid of Example 4 were measured using Photal, ELS-Z (Photal, Japan). The average particle size was 694.4 nm for PLDH and 1979.2 nm for HLDH of Example 4, and the zeta potential was +17.01 for PLDH and -11.47 for HLDH of Example 4 (Fig. 8).
[0137]
[0138] Experimental Example 4: Measurement of UV-blocking effect
[0139] As a result of measuring the UV protection effect using the cream containing avobenzone of Example 17 and Comparative Example 2, it was found that the cream containing the HLDH of the present invention of Example 17 had an increased PA (protection grade of UVA) index even with less avobenzone compared to the cream containing avobenzone as is of Comparative Example 2.
[0140]
[0141] Experimental Example 5: Measurement of moisturizing effect
[0142] After applying the cream containing hyaluronic acid of Example 18 and Comparative Example 3, the probe attached to Corneometer® CM 825 (Courage+Khazaka electronic GmbH, Germany) was placed vertically against the skin surface and lightly pressed to measure the moisture content. It was confirmed that the cream containing the HLDH of the present invention of Example 18 had a better moisturizing effect than the cream containing hyaluronic acid of Comparative Example 3 as is (Figs. 9 and 10).
[0143]
[0144] Experimental Example 6: Measurement of the effect of improving keratin
[0145] After applying the cream containing hyaluronic acid of Example 18 and Comparative Example 3, the keratin was collected from the skin surface using Corneofix F20 (Courage+Khazaka electronic GmbH, Germany), and the skin surface was analyzed using Visioscan VC98 (Courage+Khazaka electronic GmbH, Germany) to measure the keratin improvement effect. It was confirmed that the cream containing the HLDH of the present invention of Example 18 had a better keratin improvement effect than the cream containing hyaluronic acid of Comparative Example 3 as it was (Figs. 11 and 12).
[0146]
[0147] Experimental Example 7: Experiment on the effect of promoting percutaneous absorption
[0148] Neoderm, an artificial skin from Taego Science, was mounted on a Franz-type diffusion cell (Lab Fine Instruments, Korea) for an experiment. 50 mM phosphate buffer (pH 7.4, 0.1 M NaCl) was added to the receptor container (5 mL) of the Franz-type diffusion cell, and the diffusion cell was mixed and dispersed at 32°C and 600 rpm. 50 μL of each of the creams containing retinol from Example 19 and Comparative Example 4 was added to the donor container. The skin was absorbed and diffused according to the predetermined time, and the skin where absorption and diffusion occurred was 0.64 cm 2After the absorption and diffusion of the active ingredient was completed, the emulsions remaining on the skin that were not absorbed were washed off with dry kimwipes or 10 mL of ethanol, and the skin where the active ingredient was absorbed and diffused was ground using a tip-type homogenizer, and the retinol absorbed into the skin was extracted using 4 mL of dichloromethane. After that, the extract was filtered through a 0.45 μm nylon membrane, and the retinol content was measured by HPLC under the following conditions, and the results are shown in Table 4.
[0149] [Table 4]
[0150]
Claims
1. i) A mixed solution of a solution containing a divalent metal cation and a solution containing a trivalent metal cation and a NaOH solution are added to a solution containing an anion while maintaining the pH at 9 to 11; ii) Stirring the mixed solution obtained in step (i); iii) The result obtained in step (ii) is filtered using a Buchner funnel and then washed with distilled water until the pH becomes 6 to 8; iv) Add a solvent to the resultant product collected at the top of the Buchner funnel obtained in step (iii) above and then stir; v) A method for producing a hydrangea-shaped layered double hydroxide, comprising filtering the result obtained in the above step (iv) using a Buchner funnel and then drying.
2. In the first paragraph, the divalent metal cation of step (i) is Ca 2+ , Mg 2+ , Zn 2+ , Ni 2+ , Mn 2+ , Co 2+ or Fe 2+ A method for producing a hydrous layered double hydroxide characterized by:
3. In the first paragraph, the trivalent metal cation of step (i) is Al 3+ , Cr 3+ , Mn 3+ , Fe 3+ , Ga 3+ , Co 3+ or Ni 3+ A method for producing a hydrous layered double hydroxide characterized by:
4. In the first paragraph, the anion of step (i) is OH - , F - , Cl - , Br - , I - , NO3 - , CO3 2- or SO4 2- A method for producing a hydrous layered double hydroxide characterized by:
5. A method for producing a hydrous layered double hydroxide, characterized in that 2 to 5 M NaOH is used in step (i) of paragraph 1.
6. A method for producing a hydrous layered double hydroxide, characterized in that the pH of the solution containing anions in step (i) is maintained at 9.2 to 10.8 in the first paragraph.
7. A method for producing a hydrous layered double hydroxide, characterized in that the pH of the solution containing anions in step (i) is maintained at 10 ± 0.5 in the sixth paragraph.
8. A method for producing a hydrous layered double hydroxide, characterized in that in step (i), a mixed solution of a solution containing a divalent metal cation and a solution containing a trivalent metal cation and a NaOH solution are added to a solution containing an anion at a rate of 1 to 4 mL / min.
9. A method for producing a hydrous layered double hydroxide, characterized in that in step (ii) of paragraph 1, the mixed solution is stirred for 30 minutes to 2 hours.
10. A method for producing a hydrophilic layered double hydroxide, characterized in that the step (iii) further comprises washing with ethanol in the first paragraph.
11. A method for producing a hydrous layered double hydroxide, characterized in that the solvent in step (iv) is ethanol.
12. A method for producing a hydrous layered double hydroxide, characterized in that in step (iv) of paragraph 1, stirring is performed for 12 to 36 hours.
13. A method for producing a hydrophilic layered double hydroxide, characterized in that the drying in step (v) is performed at room temperature using a vacuum chamber in the first paragraph.
14. In the first paragraph, the hydrous layered double hydroxide is 200 m 2 A method for producing a hydrous layered double hydroxide characterized by having a BET surface area of / g or more.
15. A cosmetic composition comprising a hydrogel layered double hydroxide and an active ingredient manufactured by a manufacturing method according to any one of claims 1 to 14.
16. A cosmetic composition according to claim 15, characterized in that the active ingredient is selected from the group consisting of a moisturizer, a whitening agent, an anti-wrinkle agent, a UV blocker, a hair tonic, a vitamin or a derivative thereof, an amino acid or peptide, an anti-inflammatory agent, an acne treatment agent, a bactericidal agent, a female hormone agent, an exfoliating and dissolving agent, and a natural product.
Citation Information
Patent Citations
High surface area layered double hydroxides
KR1020160139003A
Comestic composition for molding, comprising calcined layered double hydroxide and polymer
KR102104924B1
Modification of layered double hydroxides
KR102121026B1
Method for preparing hydrangea-shaped layered double hydroxide
KR102630210B1
KR20190019150A
